IGF2: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD

It's the GeneMedi's summary page for Target/Biomarker Introduction of IGF2. The page also collects GeneMedi's different modalities and formats products for IGF2 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi's target-insight database-GM ITD database, the IGF2 target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Secreted Protein/Potential Cytokines.

This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]

Target IDGM-T90572
Target NameIGF2
Gene ID3481,16002,24483,710802,483664,101093644,281240,100034182
Gene Symbol and SynonymsC11orf43,GRDF,Igf-2,IGF-II,IGF2,IGFII,M6pr,Mpr,Peg2,PP9974,RNIGF2,SRS3
Uniprot AccessionP01344,P01346,P07456,P51459
Uniprot Entry NameIGF2_HUMAN,IGF2_RAT,IGF2_BOVIN,IGF2_HORSE
Protein Sub-locationSecreted Protein/Potential Cytokines
CategoryTherapeutics Target, INN Index, Cytokine Target
DiseaseOvary Cancer
Gene EnsemblENSG00000167244
Target ClassificationN/A


Pre-made IGF2-specific INN-index biosimilar (antibody&conjugates)

Anti-IGF2 therapeutic INN-index antibodies and conjugates are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody for drug discovery, target MOA research, cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Cat No.Products Name (INN Index)INN Name Previous Name Target FormatDetail
GMP-Bios-ab-634Pre-Made Xentuzumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibodyXentuzumabIGF1;IGF2Whole mAbDetail
GMP-Bios-ab-160Pre-Made Dusigitumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibodyDusigitumabIGF1;IGF2Whole mAbDetail

Click to check more INN-indexed antibody & protein biosimilar



Pre-made anti-IGF2 inhibitory monoclonal antibody(mab, blocking antibody inhibitor)-benchmark antibody for drug discovery and mechanism of action (MOA) research

Pre-made anti-IGF2 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-IGF2 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Antibody NameSpeciesFormatClassified by tagDetail
Anti-IGF2 monoclonal antibodyHuman, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, EquinemabFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibodyDetail



Recombinant multi-species IGF2/ C11orf43/ GRDF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IGF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.

Products NameSpeciesExpression PlatformDetail
IGF2 proteinHuman, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, EquineMammalian cellDetail



Cytokine Products for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces human, Cynomolgus/ Rhesus macaque, rat, mouse insulin-like growth factor 2 (IGF2) His+Avi (Biotinylated) for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.

Insulin-like growth factor 2 (IGF-2) is one of three protein hormones that share structural similarity to insulin. The MeSH definition reads: "A well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on somatotropin. It is believed to be a major fetal growth factor in contrast to Insulin-like growth factor 1, which is a major growth factor in adults.

TargetSpeciesAntigen Product NameBioactivity validation of AntigenAntibody Product NameBioactivity validation of AntibodiesDetail
IGF2Human, Cynomolgus/Rhesus macaque, rat, mouseinsulin-like growth factor 2 (IGF2) proteinAffintiy&bioactivity validated by ELISA, cell culture validatedAnti-IGF2 monoclonal antibodyBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).Detail

Click to check more Cytokine Products



Pre-made IGF2 viral vector in GM Promise-ORFTM

Cat No.Products nameNM IDSpeciesTypeDetail
vGMLV000393human IGF2 Lentivirus particleNM_001127598.2HumanLentivirus particleDetail
pGMLV000475human IGF2 Lentivirus plasmidNM_001127598.2HumanLentivirus plasmidDetail
pGMLV000393human IGF2 Lentivirus plasmidNM_001127598.2HumanLentivirus plasmidDetail
pGMAP000466Human IGF2 Adenovirus plasmidBC000531HumanAdenovirus plasmidDetail
vGMLV000475human IGF2 Lentivirus particleNM_001127598.2HumanLentivirus particleDetail
vGMAP000466Human IGF2 Adenovirus particleBC000531HumanAdenovirus particleDetail
pGMLV000050rat Igf2 Lentivirus plasmidNM_031511RatLentivirus plasmidDetail
pGMAD000117mouse Igf2 Adenovirus plasmidNM_001315489.1MouseAdenovirus plasmidDetail
pGMAAV000051mouse Igf2 AAV plasmidNM_010514.3MouseAAV plasmidDetail
pGMAAV000327house mouse Igf2 AAV plasmidNM_001315489.1House MouseAAV plasmidDetail
vGMLV000050rat Igf2 Lentivirus particleNM_031511RatLentivirus particleDetail
vGMAD000117mouse Igf2 Adenovirus particleNM_001315489.1MouseAdenovirus particleDetail
vGMAAV000051mouse Igf2 AAV particleNM_010514.3MouseAAV particleDetail
vGMAAV000327house mouse Igf2 AAV particleNM_001315489.1House MouseAAV particleDetail

About Promise-ORFTM:
Discover the largest collection of ORF/cDNA expression clones from different species, including human, mouse, rat, and more with GeneMedi's Promise-ORFTM. Our collection of ORFs expression clones come in verified mammalian or viral vectors lentivirus, AAV, and adenovirus) and our Promise-ORFTM viral-ready expression vectors make it easy for you to improve viral vector packaging efficiency or directly transfect mammalian cells, resulting in stronger and easier expression detection. Click to search your GOI

If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service.






GENEMEDI
Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
<